Zai Lab Ltd (ZLAB)
2025-06-30 | 2025-03-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|
| Product and service other | - | 283 [1] | - | - |
| Augtyro | - | 1,626 [1] | - | - |
| Nuzyra | - | 15,118 [1] | - | - |
| Optune | - | 11,363 [1] | - | - |
| Qinlock | - | 8,509 [1] | - | - |
| Vyvgart | - | 18,105 [1] | - | - |
| Xacduro | - | 1,117 [1] | - | - |
| Zejula | - | 49,529 [1] | - | - |
| Less rebates and sales returns | - | -6,683 [2] | - | - |
| Product revenue - gross | - | 112,333 [2] | - | - |
| Less rebates and sales returns | - | - | 5,831 | 6,505 |
| Product revenue - gross | - | - | 107,678 | 106,611 |
| Total revenues | 109,977 | 106,487 | 102,265 | 100,504 |
| Research and development | 50,614 | 60,729 | 65,982 | 61,625 |
| Cost of collaboration revenue | 217 | 195 | 348 | 85 |
| Cost of product revenue | 43,003 | 38,452 | 36,569 | 35,148 |
| Selling, general, and administrative | 71,038 | 63,422 | 67,219 | 79,710 |
| Loss from operations | -54,895 | -56,311 | -67,853 | -76,064 |
| Interest income | 8,843 | 8,606 | 9,029 | 9,330 |
| Interest expenses | 1,262 | 1,187 | 745 | 492 |
| Foreign currency gains (losses) | 2,837 | 651 | 14,457 | -4,108 |
| Other income (expense), net | 3,750 | -197 | 3,441 | -8,943 |
| Loss before income tax | -40,727 | -48,438 | -41,671 | -80,277 |
| Income tax expense | - | - | - | - |
| Net loss | -40,727 | -48,438 | -41,671 | -80,277 |
| Loss per share - basic (in dollars per share) | -0.04 | -0.04 | -0.04 | -0.08 |
| Loss per share - diluted (in dollars per share) | -0.04 | -0.04 | -0.04 | -0.08 |
| Weighted-average shares used in calculating net loss per ordinary share - basic (in shares) | 1,091,933,150 | 1,080,825,300 | 981,687,390 | 975,937,790 |
| Weighted-average shares used in calculating net loss per ordinary share - diluted (in shares) | 1,091,933,150 | 1,080,825,300 | 981,687,390 | 975,937,790 |